MK-4305

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-4305, covering 2016-02-22 to 2016-02-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1) [Phase 1]